Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)"
Open Access
- 14 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Virology Journal
- Vol. 17 (1), 1-5
- https://doi.org/10.1186/s12985-020-01445-4
Abstract
Several molecular kits are available for SARS-CoV-2 diagnosis, mostly lacking of proper clinical evaluation due to the emergency caused by COVID19 pandemia, particularly at developing countries like Ecuador. We carried out an evaluation of the clinical performance of "AccuPower SARS-CoV-2 Real Time RT-PCR kit" (Bioneer, South Korea) for SARS-CoV-2 diagnosis using 2019-nCoV CDC EUA kit (IDT, USA) as a gold standard. 48 clinical specimens were included on the study, 38 tested SARS-CoV-2 positive and 10 SARS-CoV-2 negative for 2019-nCoV CDC EUA kit. For "AccuPower SARS-CoV-2 Real Time RT-PCR kit", only 30 were SARS-CoV-2 positive, indicating a low clinical performance with sensitivity of 78.9%. Moreover, the limit of detection for "AccuPower SARS-CoV-2 Real Time RT-PCR kit" was estimated to be higher than 40,000 viral RNA copies/mL of sample. Proper clinical performance evaluation studies from government agencies at developing countries should be mandatory prior to clinical use authorization of SARS-CoV-2 diagnosis kits, particularly when those kits lack of either FDA or its country of origin clinical use authorization, to prevent the distribution of low quality products that may have a negative impact of COVID19 surveillance at developing countries.Keywords
Funding Information
- UDLA
This publication has 10 references indexed in Scilit:
- Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2, and RP targets for SARS-CoV-2 diagnosisInternational Journal of Infectious Diseases, 2021
- Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kitVirus Research, 2020
- “One health" inspired SARS-CoV-2 surveillance: The Galapagos Islands experienceOne Health, 2020
- Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in KoreaAnnals of Laboratory Medicine, 2020
- SARS-CoV-2 viral load assessment in respiratory samplesJournal of Clinical Virology, 2020
- Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19Journal of Clinical Microbiology, 2020
- Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’Nature, 2020
- Cotton-Tipped Plastic Swabs for SARS-CoV-2 RT-qPCR Diagnosis to Prevent Supply ShortagesFrontiers in Cellular and Infection Microbiology, 2020
- Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay KitJournal of Clinical Microbiology, 2020
- Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studiesJournal of Clinical Virology, 2020